Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25th February 2009 “Subcutaneous ustekinumab▼ (Stelara®) administered every twelve weeks was more effective than placebo for the treatment of moderate to severe psoriasis. This dosing frequency appears to maintain efficacy […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. National Institute for Health and Clinical Excellence. Adalimumab for the treatment of adults with psoriasis. NICE Technology Appraisal Guidance 146, June 2008. NICE has recently published guidance on the […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. New evidence on the safety of glitazones; Managing eczema in children – new NICE guidance; cold and cough remedies for children – help or harm?; FDA reviews the place […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. What is this about? NICE has published a clinical guideline on the management of atopic eczema in children from birth up to 12 years. What do NICE say? The […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. What is this about? While otitis externa is commonly seen in UK general practice, it is often difficult to find evidence to guide our practice in this area. […]